Maze Therapeutics

Developer of genetic bio-markers in neurological, metabolic, and renal diseases

placeRedwood City, California, United States calendar_todayFounded 2018 groups111 employees language mazetx.com

Registered entities

Social engagement

Social engagement: 27.6K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

23 investors on record; lead investors include Third Rock Ventures, Arch Venture Partners, City Hill Ventures, Matrix Capital Management; 1 has since exited.

Investor typeCountShare
Venture capital1774%
Private equity14%
Bank & private debt29%
Other / undisclosed313%

Hiring activity

Hires periodically

7 roles tracked across 5 of the last 12 months

9 Mar 2026 · Manager, Regulatory Affairs · South San Francisco

2 Mar 2026 · Senior Clinical Trial Specialist, CKD · South San Francisco

23 Feb 2026 · Director, Data Management · South San Francisco

9 Jan 2026 · Director, Clinical Sciences · South San Francisco

12 Sep 2025 · Director, Quality · South San Francisco

Based on job postings tracked across public sources.

Coming soon